Bases Neurobiológicas y Psicológicas de los Trastornos Mentales. Trastornos del Neurodesarrollo

Fernández, AG; Brenlla, E; Caro-Cañizares, I; Esteban, AC; Carballo, JJ.

Adolescent Females as a Group Particularly Vulnerable to Suicide Risk and Traumatic Stressful Life Events

EARLY INTERVENTION IN PSYCHIATRY. 2025; 19(3): [doi:10.1111/eip.70022]

Gil-Berrozpe, GJ; Segura, AG; Sánchez-Torres, AM; Amoretti, S; Giné-Servén, E; Vieta, E; Mezquida, G; Lobo, A; Gonzalez-Pinto, A; Andreu-Bernabeu, A; Roldán, A; Forte, MF; Castro, J; Bergé, D; Rodríguez, N; Ballesteros, A; Mas, S; Cuesta, MJ; Bernardo, M; PEPs Grp.

Interrelationships between polygenic risk scores, cognition, symptoms, and functioning in first-episode psychosis: A network analysis approach

EUROPEAN NEUROPSYCHOPHARMACOLOGY. 2025; 92: 52-61 [doi:10.1016/j.euroneuro.2024.12.002]

Bioque, M; Llorca-Bofi, V; MacDowell, KS; Amoretti, S; Mezquida, G; Cuesta, MJ; Diaz-Caneja, CM; Ibáñez, A; Segarra, R; González-Pinto, A; Roldán, A; Sáiz, PA; Mané, A; Lobo, A; Martínez-Pinteño, A; Cano-Escalera, G; Berrocoso, E; Bernardo, M.

Impact of Relapse in BDNF Receptors Expression in Patients With a First Episode of Schizophrenia

SCHIZOPHRENIA BULLETIN. 2025; : [doi:10.1093/schbul/sbaf012]

Ferraro, L; Di Forti, M; La Barbera, D; La Cascia, C; Morgan, C; Tripoli, G; Jongsma, H; Seminerio, F; Sartorio, C; Sideli, L; Tarricone, I; Carloni, AL; Szoke, A; Pignon, B; Bernardo, M; de Haan, L; Arango, C; Velthorst, E; Gayer-Anderson, C; Kirkbride, J; Rutten, BPF; Lasalvia, A; Tosato, S; Del Ben, CM; Menezes, PR; Bobes, J; Arrojo, M; Tortelli, A; Jones, P; Selten, JP; van Os, J; Murray, R; Quattrone, D; Vassos, E.

Cognitive presentation at psychosis onset through premorbid deterioration and exposure to environmental risk factors

PSYCHOLOGICAL MEDICINE. 2025; 55: Nº de citas: 1 [doi:10.1017/S0033291724003507]

de-la-Higuera-Gonzalez, P; Rodriguez-Toscano, E; Diaz-Carracedo, P; Gonzalez-Urrea, MJ; Padilla-Quiles, G; Diaz-Marsa, M; de la Torre-luque, A.

Memory deficits in children and adolescents with a psychotic disorder: a systematic review and meta-analysis

EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE. 2025; 275(3): 715-732 [doi:10.1007/s00406-025-01961-w]

Ortiz, M; Pueyo, A; Dongil, FJ; Boquete, L; Sánchez-Morla, EM; Barea, R; Miguel-Jimenez, JM; López-Dorado, A; Vilades, E; Rodrigo, MJ; Cordon, B; Garcia-Martin, E.

New Method of Early RRMS Diagnosis Using OCT-Assessed Structural Retinal Data and Explainable Artificial Intelligence

Translational Vision Science & Technology. 2025; 14(2): Nº de citas: 1 [doi:10.1167/tvst.14.2.14]

Stringaris, A; Burman, C; Delpech, R; Uher, R; Bhudia, D; Miliou, D; Rokas, IM; Kyriakopoulos, M; Foulkes, L; Moreno, C; Cortese, S; Lewis, G; Krebs, G.

Comparing apples and oranges in youth depression treatments? A quantitative critique of the evidence base and guidelines

Bmj Mental Health. 2025; 28(1): Nº de citas: 1 [doi:10.1136/bmjment-2024-301162]

Saracaydin, G; van Rooij, D; Kleine-Deters, R; Messchendorp, M; Naaijen, J; Penzol, MJ; Rosa, M; Aggensteiner, PM; Baumeister, S; Holz, N; Banaschewski, T; Saam, M; Schulze, UME; Sethi, A; Craig, M; Castro-Fornieles, J; Arango, C; Walitza, S; Werhahn, J; Brandeis, D; Franke, B; Ruisch, IH; Buitelaar, JK; Dietrich, A; Hoekstra, PJ.

Disentangling the neural underpinnings of response inhibition in disruptive behavior and co-occurring ADHD

EUROPEAN CHILD & ADOLESCENT PSYCHIATRY. 2025; : [doi:10.1007/s00787-025-02638-4]

Bond, BW; Duric, B; Spinazzola, E; Trotta, G; Chesney, E; Li, ZK; Quattrone, D; Tripoli, G; Gayer-Anderson, C; Rodriguez, V; Ferraro, L; La Cascia, C; Tarricone, I; Szöke, A; Arango, C; Bobes, J; Bernardo, M; Del-Ben, CM; Menezes, PR; Selten, JP; Rutten, BPF; de Haan, L; Stilo, S; Schürhoff, F; Pignon, B; Freeman, TP; Vassos, E; Murray, RM; Austin-Zimmerman, I; Di Forti, M.

Cannabis Use Cessation and the Risk of Psychotic Disorders: A Case-Control Analysis from the First Episode Case-Control EU-GEI WP2 Study: L'arrêt de l'utilisation du cannabis et le risque de troubles psychotiques: Une analyse cas-témoins tirée de l'étude cas-témoins EU-GEI WP2 centrée sur les premiers épisodes psychotiques

CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE. 2025; 70(3): 182-193 [doi:10.1177/07067437241290187]

Persico, AM; Asta, L; Chehbani, F; Mirabelli, S; Parlatini, V; Cortese, S; Arango, C; Vitiello, B.

The pediatric psychopharmacology of autism spectrum disorder: A systematic review - Part II: The future

PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY. 2025; 136: Nº de citas: 6 [doi:10.1016/j.pnpbp.2024.111176]

de Pablo, GS; Perez-Rodriguez, V; Olivares, JD; Camacho-Rubio, J; Sharma, A; Catalán, A; Breedvelt, J; Aymerich, C; Pop, M; Moreno, C; Kelleher, I; Anderson, J; Fusar-Poli, P; Correll, CU; Young, AH.

Development and predictors of bipolar disorder in children and adolescents with depressive disorders: a systematic review, meta-analysis, and meta-regression

EUROPEAN PSYCHIATRY. 2025; 68(1): [doi:10.1192/j.eurpsy.2024.1814]

Bernardo, M; Marsá, MD; González-Pinto, A; Carrasco, MM; Sola, VP; Sáiz, PA; Vieta, E; Torrens, M; Arango, C; Crespo-Facorro, B.

Efficacy of Lurasidone in First-Episode Psychosis: Patient Phenotypes, Dosage, and Recommendations from an Expert Panel

Neurology and Therapy. 2025; 14(1): 85-98 [doi:10.1007/s40120-024-00700-y]

Segura-Frontelo, A; Girela-Serrano, B; Gutiérrez-Rojas, L; Porras-Segovia, A; Peñuelas-Calvo, I; Spiers, A; Baca-García, E; Barrigón, ML; Carballo, JJ.

Prevalence and Stability of Internalizing Symptoms in Children and Adolescents: Gender Differences and Associated Factors

JOURNAL OF CHILD AND FAMILY STUDIES. 2025; 34(2): 490-501 Nº de citas: 1 [doi:10.1007/s10826-024-02987-9]

Iftimovici, A; Martinez, G; Victor, J; Bendjemaa, N; Jantac, C; Danset-Alexandre, C; Amado, I; Pina-Camacho, L; Chaumette, B; Fatjó-Vilas, M; Fañanás, L; Duchesnay, E; Krebs, MO.

Schizophrenia Following Early Adolescence Prodrome: A Neurodevelopmental Subtype With Autism-like Sensorimotor and Social Cognition Deficits

SCHIZOPHRENIA BULLETIN. 2025; : Nº de citas: 1 [doi:10.1093/schbul/sbae202]

Addington, J; Shalev, A; Liu, L; Jahraus, C; Chu, MNC; Farina, E; Poli, PF; Marcy, PJ; Nunez, AR; Calkins, ME; Alameda, L; Arango, C; Borders, O; Bouix, S; Breitborde, NJK; Broome, MR; Cadenhead, KS; Carrion, RE; Castillo-Passi, R; Chen, EYH; Choi, J; Coleman, MJ; Conus, P; Corcoran, CM; Diaz-Caneja, CM; Ellman, LM; Gaspar, PA; Gerber, C; Glenthoj, LB; Horton, LE; Hui, CLM; Kambeitz, J; Kambeitz-Ilankovic, L; Kapur, T; Kelly, S; Kerr, MJ; Keshavan, MS; Kim, M; Kim, SW; Koutsouleris, N; Kwon, JS; Langbein, K; Lewandowski, KE; Mamah, D; Mathalon, DH; Mittal, VA; Mourgues, C; Nordentoft, M; Pasternak, O; Pearlson, GD; Penzel, N; Perez, J; Perkins, DO; Powers, AR; Rogers, J; Sabb, FW; Schiffman, J; Seitz-Holland, J; Shah, JL; Silverstein, SM; Smesny, S; Stone, WS; Strauss, GP; Thompson, JL; Upthegrove, R; Verma, S; Wang, JJ; Wolf, DH; Yung, AR; Zhang, TH; Addamo, L; Buccilli, K; Todd, S; Dwyer, D; Bearden, CE; Kane, JM; Mcgorry, PD; Kahn, RS; Shenton, ME; Woods, SW; Nelson, B.

Sample Ascertainment and Recruitment Sources in the Accelerating Medicines Partnership Schizophrenia Program

Schizophrenia Bulletin Open. 2025; 6(1): [doi:10.1093/schizbullopen/sgaf013]

Arango, C; Baeza, I; García-Rizo, C; Crespo-Facorro, B; Lahera, G; Vieta, E; Becker, F; Dwyer, G; Bourke, S; Gibson, AEJ; Gabarda-Inat, I; Alvarez-Baron, E.

Exploring the Impact of Schizophrenia and Its Pharmacological Treatment on Health-Related Quality of Life and Treatment Preferences

Patient Preference and Adherence. 2025; 19: 2647-2661 [doi:10.2147/PPA.S494721]

Addington, J; Liu, L; Chu, M; Jungert, K; Penzel, N; Pasternak, O; Farina, E; Carrion, RE; Corcoran, CM; Mittal, VA; Strauss, GP; Yung, AR; Alameda, L; Arango, C; Borders, O; Bouix, S; Breitborde, NJK; Broome, MR; Cadenhead, KS; Castillo-Passi, R; Chen, EYH; Choi, J; Coleman, MJ; Conus, P; Diaz-Caneja, CM; Ellman, LM; Poli, PF; Gaspar, PA; Gerber, C; Glenthoj, LB; Horton, LE; Hui, CLM; Kambeitz, J; Kambeitz-Ilankovic, L; Kapur, T; Kelly, S; Kerr, MJ; Keshavan, MS; Kim, M; Kim, SW; Koutsouleris, N; Kwon, JS; Langbein, K; Lewandowski, KE; Mamah, D; Marcy, PJ; Mathalon, DH; Mourgues, C; Nordentoft, M; Nunez, AR; Pearlson, GD; Perez, J; Perkins, DO; Powers, AR; Rogers, J; Sabb, FW; Schiffman, J; Seitz-Holland, J; Shah, JL; Silverstein, SM; Smesny, S; Stone, WS; Thompson, JL; Upthegrove, R; Verma, S; Wang, JJ; Wolf, DH; Zhang, TH; Addamo, L; Buccilli, K; Dwyer, D; Todd, S; Cho, YT; Fontenau, C; Tamayo, Z; Bearden, CE; Kane, JM; McGorry, PD; Kahn, RS; Shenton, ME; Woods, SW; Nelson, B; Calkins, ME.

Baseline Clinical Characterization of Participants in the Accelerating Medicines Partnership Schizophrenia Program

Schizophrenia Bulletin Open. 2025; 6(1): [doi:10.1093/schizbullopen/sgaf012]

Barrigón, ML; Schmidt, C; Elices, M; Porras-Segovia, A; Granda-Beltrán, AMD; Artés-Rodríguez, A; Courtet, P; Pérez-Sola, V; Baca-García, E.

Impact of Digital Safety Plan Activation on Subsequent Emergency Departments Visits Following an Initial Suicide Attempt: Quasi-Experimental Study

JMIR Mental Health. 2025; 12: [doi:10.2196/70253]